funding-eu EU Horizon Europe HORIZON-HLTH-2027-01 HORIZON-HLTH-2027-01-DISEASE-07 Chikingunya Clinical development, Phase I Clinical trials

Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses

EU — Italia · scadenza 13/04/2027

Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses

Scadenza: 13/04/2027

Fonte: eu_funding_tenders

Tipo: EU

Pagina ufficiale: Apri la scheda sulla fonte ufficiale

Scheda (fonte ufficiale)

Topic metadata

EU Programme: Horizon Europe (ID 43108390)
Call identifier: HORIZON-HLTH-2027-01
Call name: Cluster 1 - Health (Single stage - 2027/1)
Type: Topic
Opening date: 10/02/2027
Next deadline: 13/04/2027
Keywords: HORIZON-HLTH-2027-01-DISEASE-07, HORIZON-HLTH-2027-01, Chikingunya, Clinical development, Phase I, Clinical trials, Crimean Congo Haemorrhagic Fever, Disease control, Drug development, clinical phases

Topic description

Expected Outcome:

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:

The scientific and clinical

Iscriviti o accedi per leggere e ricevere aggiornamenti sui finanziamenti.

Iscriviti ora